Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper

KRT8 Reaktivität: Human, Rind (Kuh), Schwein, Kaninchen, Schaf IF, IHC, FACS, StM Wirt: Maus Monoclonal B22-1 unconjugated
Produktnummer ABIN6939880
  • Target Alle KRT8 Antikörper anzeigen
    KRT8 (Keratin 8 (KRT8))
    Reaktivität
    • 247
    • 81
    • 76
    • 31
    • 31
    • 29
    • 29
    • 16
    • 14
    • 10
    • 7
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Rind (Kuh), Schwein, Kaninchen, Schaf
    Wirt
    • 132
    • 124
    • 2
    • 1
    Maus
    Klonalität
    • 129
    • 128
    Monoklonal
    Konjugat
    • 137
    • 23
    • 17
    • 9
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Dieser KRT8 Antikörper ist unkonjugiert
    Applikation
    • 164
    • 96
    • 88
    • 82
    • 67
    • 50
    • 41
    • 40
    • 32
    • 29
    • 23
    • 18
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Immunofluorescence (IF), Immunohistochemistry (IHC), Flow Cytometry (FACS), Staining Methods (StM)
    Keine Kreuzreaktivität
    Huhn, Maus, Ratte (Rattus), Xenopus laevis
    Aufreinigung
    Purified by Protein A/G
    Immunogen
    Cytoskeletal preparation from HeLa cells
    Klon
    B22-1
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product KRT8 Primärantikörper
  • Applikationshinweise

    Positive Control: MCF-7 or A431 cells. Skin, colon, lung or breast carcinoma.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    KRT8 (Keratin 8 (KRT8))
    Andere Bezeichnung
    KRT8 (KRT8 Produkte)
    Synonyme
    CARD2 antikoerper, CK-8 antikoerper, CK8 antikoerper, CYK8 antikoerper, K2C8 antikoerper, K8 antikoerper, KO antikoerper, AA960620 antikoerper, AL022697 antikoerper, AU019895 antikoerper, Card2 antikoerper, EndoA antikoerper, Krt-2.8 antikoerper, Krt2-8 antikoerper, CYKER antikoerper, KRT2-8 antikoerper, KERATIN8 antikoerper, ck8 antikoerper, cyk8 antikoerper, k2c8 antikoerper, card2 antikoerper, krt2-5 antikoerper, MGC69490 antikoerper, KRT8 antikoerper, DreK8 antikoerper, cb186 antikoerper, krt2-8 antikoerper, sb:cb186 antikoerper, wu:fa20h05 antikoerper, wu:fa95h10 antikoerper, wu:fb96c06 antikoerper, zf-K8 antikoerper, zfk8 antikoerper, DKFZp468F2127 antikoerper, keratin 8 antikoerper, keratin 8 S homeolog antikoerper, KRT8 antikoerper, Krt8 antikoerper, krt8.S antikoerper, krt8 antikoerper
    Hintergrund
    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast.
    Molekulargewicht
    52.5kDa
    Gen-ID
    3856
    UniProt
    P05787
Sie sind hier:
Kundenservice